Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells. It is not
yet known which regimen of combination chemotherapy is more effective in treating patients
with recurrent or metastatic colorectal cancer.
PURPOSE: Randomized phase III trial to study the effectiveness of combining fluorouracil,
leucovorin, and oxaliplatin in different ways in treating patients with recurrent or
metastatic colorectal cancer.
Phase:
Phase 3
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC